The FDA is again looking into the safety of the abortion drug mifepristone following a Louisiana court order and calls from Republican lawmakers to investigate

AbbVie filed suit against the federal government on Wednesday over its interpretation of the word “patient” under the 340B federal drug discount program. The lawsuit

Deals deals deals. Biopharma M&A is having one of its best stretches in years, as big pharma buyers snap up smaller biotechs. We’ll be talking

Plus, news about Boston Oncology, Garda and Assertio, an Everest deal and Forte’s raise: 🟢 FDA ends partial hold on MacroGenics cancer drug: In February,

AI chatbots are no longer enough to stand out in mental health. Plenty of companies have been building them for therapy, adding them as part